1. Pattanapanyasat K, Thepthai C, Lamchiagdhase P, LerdwanaS. Lymphocyte subsets and spesific T cell immune response inthalassemia. Cytometry. 2000;42(1):11-17.
2. Modell B, Darlison M. Global epidemiology of haemoglobindisorders and derived service indicators. Bull World Health Organ.2008;86(6):480-487.
3. Canatan D. Haemoglobinopathy prevention program in Turkey.Thalassemia Rep. 2011;1(S2):e4.
4. Kountouris P, Lederer CW, Fanis P, Feleki X, Old J, Kleanthous M.IthaGenes: an interactive database for haemoglobin variations andepidemiology. PLoS One. 2014;9(7):e103020.
5. Gluba-Brzózka A, Franczyk B, Rysz-Górzynska M, RokickiR, Koziarska-Rosciszewska M, Rysz J. Pathomechanisms ofimmunological disturbances in β-thalassemia. Inter J Molecul Sci.2021;22(18):9677.
6. Ladis V, Chouliaras G, Bedousi H, et al. Longitudinal study of survivaland causes of death in patients with thalassemia major in Greece. AnnN Y Acad Sci. 2005;1054(1):445-450.
7. Ghaffari J, Vahidshahi K, Kosaryan M, Soltantooyeh Z, MohamadiM. Humeral immune system state in β thalassemia major. Med Glas(Zenica). 2011;8(2):192-196.
8. Papanıkolaou G, Pantopoulos K. Iron metabolism and toxicity. ToxicolApp Pharmacol. 2005;202(2):199-211.
9. Farmakis D, Giakoumis A, Polymeropoulos E, Aessopos A.Pathogenetic aspects of immune deficiency associated with beta-thalassemia. Med Sci. Monit. 2003;9:22.
10. Ezer Ü, Gülderen F, Çulha VK, Akgül N, Gürbüz Ö. Immunologicalstatus of thalassemia syndrome. Pediat Hematol Oncol. 2002;19(1):51-58.
11. Rakhmanova UU, Yusupova IA, Bobojonova ShD, Rustamova NX.Diagnostic and predictive significance of immunological disorders inβ-Thalassemia. 2021.
12. Ehsanipour F, Faranoush P, Foroughi-Gilvaee MR, et al. Evaluationof immune system in patients with transfusion-dependent beta-thalassemia in Rasoul-e-Akram Hospital in 2021: a descriptive cross-sectional study. Health Sci Rep. 2022;5(6):e871.